PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $228,920 | -3.0% | 5,713 | -1.2% | 0.00% | – |
| Q1 2023 | $235,963 | -6.7% | 5,782 | +21.8% | 0.00% | -100.0% |
| Q3 2022 | $253,000 | +10.0% | 4,749 | +20.6% | 0.00% | 0.0% |
| Q2 2022 | $230,000 | -32.2% | 3,939 | -11.3% | 0.00% | 0.0% |
| Q1 2022 | $339,000 | +48.7% | 4,439 | +18.1% | 0.00% | – |
| Q2 2021 | $228,000 | -38.7% | 3,759 | -29.1% | 0.00% | -100.0% |
| Q1 2021 | $372,000 | +52.5% | 5,303 | +30.0% | 0.00% | 0.0% |
| Q4 2020 | $244,000 | -7.2% | 4,079 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $263,000 | -22.9% | 4,382 | -32.5% | 0.00% | 0.0% |
| Q2 2020 | $341,000 | +48.3% | 6,490 | -5.2% | 0.00% | 0.0% |
| Q1 2020 | $230,000 | -14.8% | 6,847 | +14.8% | 0.00% | 0.0% |
| Q4 2019 | $270,000 | +15.9% | 5,963 | +11.2% | 0.00% | 0.0% |
| Q2 2019 | $233,000 | -3.3% | 5,361 | -4.3% | 0.00% | 0.0% |
| Q4 2018 | $241,000 | -1.6% | 5,602 | +12.2% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | – | 4,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |